Lynn Cheatham
Overview
Explore the profile of Lynn Cheatham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cotten C, Fisher K, Malcolm W, Gustafson K, Cheatham L, Marion A, et al.
Stem Cells Transl Med
. 2023 Jun;
12(6):355-364.
PMID: 37285522
Hypoxic ischemic encephalopathy (HIE) in neonates causes increased mortality and long-term morbidity in surviving babies. Hypothermia (HT) has improved outcomes, however, mortality remains high with ~half of surviving babies developing...
2.
Shaz B, Kraft B, Troy J, Poehlein E, Chen L, Cheatham L, et al.
Stem Cells Transl Med
. 2023 Mar;
12(4):185-193.
PMID: 36929827
Background: Treatment options for patients with COVID-19-related acute respiratory distress syndrome (ARDS) are desperately needed. Allogeneic human umbilical cord derived mesenchymal stromal cells (hCT-MSCs) have potential therapeutic benefits in these...
3.
Hale L, Cheatham L, Macintyre A, LaFleur B, Sanders B, Troy J, et al.
Geroscience
. 2021 Jan;
43(3):1369-1382.
PMID: 33420705
Human age-related thymus involution is characterized by loss of developing thymocytes and the thymic epithelial network that supports them, with replacement by adipose tissue. The mechanisms that drive these changes...
4.
Hale L, Neff J, Cheatham L, Cardona D, Markert M, Kurtzberg J
PLoS One
. 2020 Mar;
15(3):e0230668.
PMID: 32208448
The maintenance and propagation of complex mixtures of cells in vitro in the form of native organs or engineered organoids has contributed to understanding mechanisms of cell and organ development...
5.
Muniz Alers S, Page K, Simmons R, Waters-Pick B, Cheatham L, Troy J, et al.
Transfusion
. 2018 Oct;
58(12):2911-2917.
PMID: 30307045
Background: The cell dose infused for cord blood transplantation strongly correlates with outcomes following transplantation. Post thaw recoveries can be improved by washing cord blood units (CBUs) in dextran/albumin. Early...
6.
Shoulars K, Noldner P, Troy J, Cheatham L, Parrish A, Page K, et al.
Blood
. 2016 Mar;
127(19):2346-54.
PMID: 26968535
Banked, unrelated umbilical cord blood provides access to hematopoietic stem cell transplantation for patients lacking matched bone marrow donors, yet 10% to 15% of patients experience graft failure or delayed...
7.
Popa-Burke I, Birkos S, Blackwell L, Cheatham L, Clark J, Dickson Jr J, et al.
Curr Top Med Chem
. 2005 Sep;
5(10):941-51.
PMID: 16178739
The p38 MAP kinases are a family of serine/threonine protein kinases that play a key role in cellular pathways leading to pro-inflammatory responses. We have developed and implemented a method...
8.
Fingar D, Richardson C, Tee A, Cheatham L, Tsou C, Blenis J
Mol Cell Biol
. 2003 Dec;
24(1):200-16.
PMID: 14673156
The mammalian target of rapamycin (mTOR) integrates nutrient and mitogen signals to regulate cell growth (increased cell mass and cell size) and cell division. The immunosuppressive drug rapamycin inhibits cell...